Daniel Albertson, MD | ARUP Laboratories

Daniel Albertson, MD

Daniel Albertson, MD

Division Chief: Anatomic Pathology and Molecular Oncology
Subspecialties: Genitourinary, gynecologic, breast, sarcoma, FISH, and autopsy pathology

Associate Professor (Clinical), University of Utah School of Medicine

Specialties

Fish Pathology
Breast
Sarcoma pathology
Genitourinary pathology
Gynecologic pathology

Education

Medical Degree—University of Nebraska
Residency—Anatomic and Clinical Pathology, Creighton University
Fellowship—Surgical Pathology, University of Utah

Certification/Affiliations

United States and Canadian Academy of Pathology
College of American Pathologists

Research Interests

Oncologic genitourinary and gynecologic pathology
Solid tumor FISH pathology
Applications of digital pathology

Awards

Hal Lankford Pathology Resident Award, University of Nebraska, 2011
Outstanding Teaching Award in Anatomic Pathology, University of Utah, 2017
The Joe Holden Award for Clinical Excellence in Anatomic Pathology, 2018

Recent Publications

Stenehjem DD, et al. Predictive genomic markers of response to VEGF targeted therapy in metastatic renal cell carcinoma. PLoS One. 2019;14(1):e0210415
Gupta S, et al. Histone deacetylase inhibition has targeted clinical benefit in ARID1A-mutated advanced urothelial carcinoma. Mol Cancer Ther. 2019;18(1):185–95.
Tward JD, et al. Demographics, stage distribution, and relative roles of surgery and radiotherapy on survival of persons with primary prostate sarcomas. Cancer Med. 2018;7(12):6030–9.
Gupta S, et al. Comprehensive genomic sequencing of urothelial tumors identifies rare SMARCB1 (INI-1)-deficient carcinomas of the urinary system. Clin Genitourin Cancer. 2018;16(2):e373–82.
Kuzman JA, et al. Neutrophil-lymphocyte ratio as a predictive biomarker for response to high dose interleukin-2 in patients with renal cell carcinoma. BMC Urol. 2017;17(1):1.